Zebrafish model explains how recurring cancer may resist treatment
Friday, July 21, 2017
UT Health San Antonio researchers are learning how stem cell biology causes 30 percent of children who have a rare muscle cancer to relapse and not respond to treatment.
To do this, the lab of Myron Ignatius, Ph.D., at UT Health’s Greehey Children’s Cancer Research Institute, is using zebrafish. These fish have the unusual trait of being translucent. “Zebrafish are like a glass of water. You can see right through them,” said Dr. Ignatius, assistant professor of molecular medicine at UT Health. view more
KTSA Radio: What do we know about Sen. McCain’s brain tumor?
Friday, July 21, 2017
What’s next for Arizona Senator John McCain following his shocking brain cancer diagnosis?
Read the full story at KTSA Radio
The post KTSA Radio: What do we know about Sen. McCain’s brain tumor? appeared first on UT Health Science Center News.
Cancer Center offering free skin cancer screenings
Wednesday, July 19, 2017
With temperatures rising and little rain in sight, San Antonians are getting an extreme dose of sunshine. With that comes an increased risk of skin cancer, the most commonly diagnosed cancer in the U.S., according to the American Cancer Society.
UT Health Cancer Center, part of UT Health San Antonio, is offering free skin cancer screenings from 5:30 to 7:30 p.m. on Thursday, Aug. 10. The screenings will be held at UT Health Cancer Center, 7979 Wurzbach Road. view more
BRCA1 discovery has implications for breast and ovarian cancer research
Tuesday, July 18, 2017
The human body holds many mysteries, and function of the BRCA1 gene is among them. Women who inherit a faulty copy of BRCA1 have up to a 65 percent chance to develop breast cancer by age 70. They also have up to a 39 percent chance to develop ovarian cancer.
Rong Li, Ph.D., and colleagues at UT Health San Antonio are building on 15 years of BRCA1 studies. Their latest discovery, reported June 26 in Nature Communications, is of a new, previously unrecognized function of BRCA1. view more
Foundation increases grant for liver cancer research
Thursday, June 22, 2017
The Clayton Foundation for Research is supporting UT Health San Antonio in the development of a biorepository and new strategies for treating hepatocellular carcinoma (HCC), which is the most common liver cancer in adults. The gift originally provided $300,000 in research support each year for five years, but the foundation recently increased the grant to $500,000 for the next fiscal year. view more
Voelcker Fund approves $2.3 million for UT Health research
Friday, June 16, 2017
Six new grants in 2017 bring cumulative giving by the Fund to $20.7 million
Trustees of the Max and Minnie Tomerlin Voelcker Fund have approved more than $2.3 million in new research funding for rising investigators at The University of Texas Health Science Center, now called UT Health San Antonio. William L. Henrich, M.D., MACP, president of UT Health, announced the funding today. view more
National Cancer Institute awards Curiel lab $3.3M
Monday, June 12, 2017
Provocative Questions grant, rarely given, funds out-of-the-box immunotherapy studies
Tyler J. Curiel, M.D., M.P.H., of the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has been awarded a five-year, $3.3 million Provocative Questions grant by the National Cancer Institute.
Dr. Curiel and his colleagues seek to optimize the effectiveness of immune-checkpoint drugs in treating melanoma and other cancers. view more
Study: Radiation may be as good as surgery in treating bladder cancer
Tuesday, June 6, 2017
Radiation therapy may be as good as bladder surgery at helping patients survive advanced bladder cancer, a new UT Health San Antonio study shows.
Researchers analyzed outcomes from more than 12,000 patients worldwide to compare survival of those who had radical cystectomy surgery versus those who had radiation. The result could influence decision-making by patients and their physicians in the treatment of muscle-invasive bladder cancer. view more
New breast, brain research among UT Health posters to be presented at ASCO
Thursday, June 1, 2017
Early results of a first-in-human clinical trial of a new breast cancer drug, and preliminary findings of a new viral treatment for brain cancer are among the posters to be presented by UT Health San Antonio cancer researchers at the American Society of Clinical Oncology meeting June 2-6 in Chicago.
Approximately 15 posters involving more than 30 UT Health researchers will be presented. Here is a sampling of some of the posters: view more
Study: Younger women with breast cancer should lose weight
Monday, May 22, 2017
Obesity and weight gain have long been risk factors associated with death from breast cancer. In a recent study published in the journal Cancer, a multi-institutional team of researchers, headed by Virginia Kaklamani, M.D., from UT Health San Antonio, focused on the factors that affect weight gain in women diagnosed with breast cancer. view more